ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ROIVW Roivant Sciences Ltd

2.75
0.00 (0.00%)
14 Mar 2025 - Closed
Delayed by 15 minutes

Roivant Sciences Financial Summary

The current ROIVW market cap is 2.22B. The company's latest EPS is USD 5.3967 and P/E is 1.98.

Year End 31 March 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 67.69M23.8M55.29M61.28M124.8M
Operating Income -553.81M-1.07B-1.35B-1.18B-1.11B
Net Income 1.2B-809.23M-845.26M-1.01B4.35B
Year End 31 March 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 2.48B2.59B2.59B2.39B7.22B
Total Liabilities 368.36M527.69M523.7M782.02M773.95M
Total Equity 2.09B2.04B2.04B1.61B6.45B
Year End 31 March 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -758.75M-552.14M-677.73M-843.39M-765.27M
Investing 1.69B-31.7M303.3M-44.27M5.2B
Financing 214.08M456.26M306.79M499.46M419.36M
Market Cap 2.22B
Price to Earnings Ratio 1.98
Price to Sales Ratio 68.88
Price to Cash Ratio 1.32
Price to Book Ratio 1.33
Dividend Yield -

Share Statistics

Shares Outstanding 805.85M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.4 (15.38%)

Company Info

Company Name Roivant Sciences Ltd
Address clarendon house
hamilton D0 HM11
Website https://www.roivant.com
Industry pharmaceutical preparations (2834)